Does FOLLITROPIN Cause Product use issue? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Product use issue have been filed in association with FOLLITROPIN (Gonal-f RFF Redi-ject). This represents 0.8% of all adverse event reports for FOLLITROPIN.
21
Reports of Product use issue with FOLLITROPIN
0.8%
of all FOLLITROPIN reports
0
Deaths
9
Hospitalizations
How Dangerous Is Product use issue From FOLLITROPIN?
Of the 21 reports, 9 (42.9%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOLLITROPIN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does FOLLITROPIN Cause?
Ovarian hyperstimulation syndrome (718)
Ascites (213)
No adverse event (213)
Abdominal distension (154)
Headache (151)
Nausea (129)
Abdominal pain (115)
Product quality issue (111)
Abortion spontaneous (102)
Dyspnoea (101)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which FOLLITROPIN Alternatives Have Lower Product use issue Risk?
FOLLITROPIN vs FOLLITROPIN ALFA
FOLLITROPIN vs FOLLITROPIN BETA
FOLLITROPIN vs FOLLITROPIN\LUTEINIZING HORMONE
FOLLITROPIN vs FOLLITROPIN\LUTROPIN ALFA
FOLLITROPIN vs FONDAPARINUX